The antiviral activity of myricetin against pseudorabies virus through regulation of the type I interferon signaling pathway

PRV, belonging to the <i>Herpesviridae</i> family, is an easily overlooked zoonotic pathogen that can threaten human health. The immunoprotective efficacy of conventional vaccines is significantly reduced due to the continuous mutation of the PRV genome, which constantly generates new viral strains. Therefore, there is a need to develop potent therapeutic drugs. PRV is capable of evading the host's natural immunity by suppressing the host's type I interferon signaling pathway, and the search for drugs that activate natural immunity can induce the body to produce type I IFN interferon and exert antiviral effects. Accordingly, the present study sought to identify active compounds from flavonoids that modulate the type I IFN interferon signaling pathway and thus inhibit the proliferation of PRV, which provides a new idea for the development of anti-PRV drugs from flavonoids that modulate the type I IFN interferon signaling pathway to enhance the body's antiviral immunity.

Authors

Institutions

Publication Details

Journal
Journal of Virology
Published
2024-11-27
DOI
https://doi.org/10.1128/jvi.01567-24
Citations
6
Primary Topic
Herpesvirus Infections and Treatments
Type
article
Field-Weighted Citation Impact
2.32

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The antiviral activity of myricetin against pseudorabies virus through regulation of the type I interferon signaling pathway

Yaqin Chen, Yuanfeng Zou, Xingyue Yu, Y. Zhang et al.
6 citations
Journal of Virology
Herpesvirus Infections and Treatments
2.32
article

The antiviral activity of myricetin against pseudorabies virus through regulation of the type I interferon signaling pathway

Yaqin Chen, Yuanfeng Zou, Xingyue Yu, Y. Zhang, Tao He, Xu Song, Xufan Zhao, Yizhen Song, Renyong Jia, Zhongqiong Yin, Xinghong Zhao, Dongmei Zhang, Mingyue Li, Lixia Li, Tianli Su, Xun Zhou, Juan Wang
article en
6 citations

Abstract

PRV, belonging to the <i>Herpesviridae</i> family, is an easily overlooked zoonotic pathogen that can threaten human health. The immunoprotective efficacy of conventional vaccines is significantly reduced due to the continuous mutation of the PRV genome, which constantly generates new viral strains. Therefore, there is a need to develop potent therapeutic drugs. PRV is capable of evading the host's natural immunity by suppressing the host's type I interferon signaling pathway, and the search for drugs that activate natural immunity can induce the body to produce type I IFN interferon and exert antiviral effects. Accordingly, the present study sought to identify active compounds from flavonoids that modulate the type I IFN interferon signaling pathway and thus inhibit the proliferation of PRV, which provides a new idea for the development of anti-PRV drugs from flavonoids that modulate the type I IFN interferon signaling pathway to enhance the body's antiviral immunity.

Journal of VirologyVol. 99(1)
Sichuan Agricultural University (CN)
China Agricultural Research System, Natural Science Foundation of Sichuan Province, Sichuan Veterinary Medicine and Drug Innovation Group of China Agricultural Research System, Chengdu Science and Technology Program
Good health and well-being
Openalex Percentile: Top 10%
Herpesvirus Infections and Treatments
2.32
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.